title: CTNNB1, AXIN1 and APC expression analysis of different medulloblastoma variants.
abstract: OBJECTIVE
  We investigated four components of the Wnt signaling pathway in medulloblastomas. Medulloblastoma is the most common type of malignant pediatric brain tumor, and the Wnt signaling pathway has been shown to be activated in this type of tumor.
  
  
  METHODS
  Sixty-one medulloblastoma cases were analyzed for β-catenin gene (CTNNB1) mutations, β-catenin protein expression via immunostaining and Wnt signaling pathway-related gene expression. All data were correlated with histological subtypes and patient clinical information.
  
  
  RESULTS
  CTNNB1 sequencing analysis revealed that 11 out of 61 medulloblastomas harbored missense mutations in residues 32, 33, 34 and 37, which are located in exon 3. These mutations alter the glycogen synthase kinase-3β phosphorylation sites, which participate in β-catenin degradation. No significant differences were observed between mutation status and histological medulloblastoma type, patient age and overall or progression-free survival times. Nuclear β-catenin accumulation, which was observed in 27.9% of the cases, was not associated with the histological type, CTNNB1 mutation status or tumor cell dissemination. The relative expression levels of genes that code for proteins involved in the Wnt signaling pathway (CTNNB1, APC, AXIN1 and WNT1) were also analyzed, but no significant correlations were found. In addition, large-cell variant medulloblastomas presented lower relative CTNNB1 expression as compared to the other tumor variants.
  
  
  CONCLUSIONS
  A small subset of medulloblastomas carry CTNNB1 mutations with consequent nuclear accumulation of β-catenin. The Wnt signaling pathway plays a role in classic, desmoplastic and extensive nodularity medulloblastoma variants but not in large-cell medulloblastomas.
authors.affiliation: Laboratory of Molecular and Cellular Biology, Department of Neurology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, SP, Brazil.
authors.forename: Roseli da
authors.initials: Rd
authors.lastname: Silva
authors.forename: Suely K N
authors.initials: SK
authors.lastname: Marie
authors.forename: Miyuki
authors.initials: M
authors.lastname: Uno
authors.forename: Hamilton
authors.initials: H
authors.lastname: Matushita
authors.forename: Alda
authors.initials: A
authors.lastname: Wakamatsu
authors.forename: Sergio
authors.initials: S
authors.lastname: Rosemberg
authors.forename: Sueli M
authors.initials: SM
authors.lastname: Oba-Shinjo
mesh_terms: D025601:Adenomatous Polyposis Coli Protein / Q000032:analysis* / Q000378:metabolism; D000328:Adult; D060466:Axin Protein / Q000032:analysis* / Q000378:metabolism; D002528:Cerebellar Neoplasms / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D016009:Chi-Square Distribution; D002648:Child; D018572:Disease-Free Survival; D005260:Female; D015870:Gene Expression; D006801:Humans; D008297:Male; D008527:Medulloblastoma / Q000235:genetics / Q000378:metabolism / Q000473:pathology*; D060888:Real-Time Polymerase Chain Reaction; D018709:Statistics, Nonparametric; D060449:Wnt Signaling Pathway; D051176:beta Catenin / Q000032:analysis* / Q000378:metabolism
chemical_list: C555451:AXIN1 protein, human; D025601:Adenomatous Polyposis Coli Protein; D060466:Axin Protein; C495270:CTNNB1 protein, human; D051176:beta Catenin